Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: A clinicopathologic study in atrophic-erosive and reticular form

Journal of Oral Pathology and Medicine

Volumn 38, Issue 7, 2009, Pages 559-564

  Zhou, Gang ^a   Xia, Kun ^a   Du, Ge Fei ^a   Chen, Xin Ming ^a   Xu, Xue Yi ^a   Lu, Rui ^a   Zhou, Hong Mei ^b  

^a WUHAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Nuclear factor kappa B p65; Oral lichen planus; Tumor necrosis factor alpha

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DISEASE CLASSIFICATION; EPITHELIUM BASAL CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LICHEN PLANUS; MALE; MOUTH MUCOSA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN BIOPSY;

ADULT; AGED; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; REFERENCE VALUES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 70350291655     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00779.x     Document Type: Article

References (25)

1. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13: 350-365
2. Li Q, Verma IM. NF-jB regulation in the immune system. Nature Rev Immunol 2002; 2: 725-734
3. Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F. NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 2003; 201: 466-472
4. Karatsaidis A, Hayashi K, Schreurs O, Helgeland K, Schenck K. Survival signalling in keratinocytes of erythematous oral lichen planus. J Oral Pathol Med 2007; 36: 215-222
5. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071
6. WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518-539
7. Xue JL, Fan MW, Wang SZ, Chen X-M, Li Y, Wang L. A clinical study of 674 patients with oral lichen planus in China. J Oral Pathol Med 2005; 34: 467-472
8. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985; 60: 308-315
9. Eisenberg E. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 2000; 58: 1278-1285
10. Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol 1988; 17: 213-218
11. Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985; 60: 30-34
12. Bagá n-Sebastián JV, Milián-Masanet MA, Penarrocha- Diago M, Jiménez Y. A clinical study of 205 patients with oral lichen planus. J Oral Maxillofac Surg 1992; 50: 116-118
13. Moynagh PN. The NF-kappaB pathway. J Cell Sci 2005; 118: 4589-4592
14. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344-362
15. Zhang J, Peng B, Chen X. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 2005; 11: 7334-7343
16. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003; 32: 77-83.
17. Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, Garinis GA, Karameris A. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas / Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med 2004; 33: 386-390
18. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 40-51. (Pubitemid 40813390)
19. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro-inflammatory, NF-kappaBdependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 2005; 114: 278-283
20. Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene 2006; 25: 6758-6780
21. Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 2002; 35: 28-40.
22. Kolenko V, Bloom T, Rayman P, Bukowski R, Hsi E, Finke J. Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol 1999; 163: 590-598
23. Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Role of NF-kappaB in the apoptoticresistant phenotype of keratinocytes. J Biol Chem 1999; 274: 37957-37964
24. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274: 782-784
25. Dale E, Davis M, Faustman DL. A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response. Adv Physiol Educ 2006; 30: 152-158